Takafumi Hiro Selected Research

Sirolimus (Rapamycin)

2/2008

Late giant coronary aneurysm associated with a fracture of sirolimus eluting stent: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takafumi Hiro Research Topics

Disease

22	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 11/2006
16	Acute Coronary Syndrome 01/2020 - 12/2006
10	Atherosclerotic Plaque (Atheroma) 01/2021 - 06/2005
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 09/2010
6	Stable Angina 10/2021 - 02/2008
6	Atherosclerosis 10/2017 - 02/2007
5	Myocardial Infarction 01/2018 - 01/2014
4	Thrombosis (Thrombus) 01/2015 - 09/2011
3	Hypercholesterolemia 01/2019 - 02/2007
3	Diabetes Mellitus 01/2016 - 06/2010
2	Atrial Fibrillation 01/2023 - 01/2022
2	Neointima 01/2022 - 12/2019
2	Pathologic Constriction (Stenosis) 01/2018 - 10/2005
2	Rupture 01/2018 - 10/2014
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2016 - 02/2016
2	ST Elevation Myocardial Infarction 04/2016 - 02/2016
2	Reperfusion Injury 04/2016 - 02/2016
2	Aneurysm (Aneurysms) 01/2016 - 02/2008
2	Heart Failure 01/2016 - 01/2002
2	Coronary Disease (Coronary Heart Disease) 07/2012 - 02/2007
1	Syncope (Fainting) 01/2020
1	Prodromal Symptoms 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Dyslipidemias (Dyslipidemia) 06/2018
1	Coronary Occlusion 01/2018
1	Hemorrhage 04/2016
1	Infarction (Infarctions) 04/2016
1	Myocardial Reperfusion Injury 04/2016
1	Hyperemia 06/2013
1	Hyperglycemia 06/2013
1	Left Ventricular Outflow Obstruction 06/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2011
1	Ventricular Tachycardia 01/2011
1	Coronary Aneurysm (Aneurysm, Coronary) 02/2008

Drug/Important Bio-Agent (IBA)

22	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 12/2006
16	pitavastatin (itavastatin)FDA Link 01/2023 - 12/2006
15	LipidsIBA 01/2023 - 06/2005
11	Atorvastatin (Lipitor)FDA Link 01/2019 - 12/2006
7	LDL CholesterolIBA 10/2022 - 02/2007
7	Rosuvastatin Calcium (Crestor)FDA Link 01/2019 - 02/2007
5	oxidized low density lipoproteinIBA 01/2019 - 10/2012
3	Phenobarbital (Luminal)FDA Link 01/2020 - 10/2005
2	omega-Chloroacetophenone (Mace)IBA 01/2023 - 09/2010
2	HDL CholesterolIBA 01/2022 - 09/2010
2	alirocumabIBA 01/2019 - 01/2018
2	Fluspirilene (Imap)IBA 10/2017 - 01/2016
2	3- guanidinocarbonyl- 2- methyl- 6,7,8,9- tetrahydro- 5H- cyclohepta(b)pyridine- 9- ylmethyl sulfuric acidIBA 04/2016 - 02/2016
2	Sodium-Hydrogen ExchangersIBA 04/2016 - 02/2016
2	MetalsIBA 10/2014 - 09/2011
1	pro-brain natriuretic peptide (1-76)IBA 01/2023
1	Troponin IIBA 01/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021
1	Prasugrel Hydrochloride FDA Link 01/2020
1	Clopidogrel (Plavix)FDA Link 01/2020
1	2',4'-dichlorobenzamil amiloride (DCBA)IBA 12/2019
1	saxagliptin FDA Link 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	CholesterolIBA 01/2018
1	Ezetimibe (Zetia)FDA Link 10/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2017
1	lixisenatideIBA 10/2017
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2017
1	LDL Receptors (LDL Receptor)IBA 04/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	DiureticsIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Tolvaptan FDA Link 01/2016
1	miglitol (Glyset)FDA Link 06/2013
1	Glycoside Hydrolase InhibitorsIBA 06/2013
1	Dobutamine FDA LinkGeneric 06/2013
1	Advanced Glycation End ProductsIBA 01/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2013
1	CreatinineIBA 10/2012
1	Glucose (Dextrose)FDA LinkGeneric 07/2012
1	azelnidipineIBA 01/2011
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2011
1	Polyvinyl Chloride (PVC)IBA 01/2011
1	AdiponectinIBA 09/2010
1	Triglycerides (Triacylglycerol)IBA 09/2010
1	remnant-like particle cholesterolIBA 06/2010
1	Polytetrafluoroethylene (Teflon)FDA Link 02/2008
1	Sirolimus (Rapamycin)FDA Link 02/2008

Therapy/Procedure

23	Therapeutics 01/2023 - 07/2009
8	Stents 12/2019 - 05/2002
7	Percutaneous Coronary Intervention 06/2021 - 02/2008
4	Drug-Eluting Stents 01/2022 - 09/2011
1	Catheter Ablation 01/2023
1	Aftercare (After-Treatment) 12/2019
1	Intravenous Infusions 04/2016
1	Sutures (Suture) 01/2016
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2016
1	Perioperative Period 01/2015
1	Secondary Prevention 12/2014
1	Drug Therapy (Chemotherapy) 01/2013